To prevent this, Li et al. fused a scFv targeting CS1, which is expressed on all normal NK cells, but not CD19+ tumour cells, with the transmembrane domain and inhibitory domain of the inhibitory KIR, KIR2DL1[11]. This evidence concerns the gene CD19 and neoplasm.